Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Non Operating Investment Income (2022 - 2025)

Historic Non Operating Investment Income for Treace Medical Concepts (TMCI) over the last 4 years, with Q3 2025 value amounting to $33000.0.

  • Treace Medical Concepts' Non Operating Investment Income fell 8479.26% to $33000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$108000.0, marking a year-over-year decrease of 13185.84%. This contributed to the annual value of -$66000.0 for FY2024, which is 13473.68% down from last year.
  • Treace Medical Concepts' Non Operating Investment Income amounted to $33000.0 in Q3 2025, which was down 8479.26% from -$7000.0 recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Non Operating Investment Income peaked at $311000.0 during Q4 2023, and registered a low of -$163000.0 during Q2 2023.
  • For the 4-year period, Treace Medical Concepts' Non Operating Investment Income averaged around $6916.7, with its median value being -$28000.0 (2022).
  • In the last 5 years, Treace Medical Concepts' Non Operating Investment Income skyrocketed by 125185.19% in 2023 and then crashed by 22413.79% in 2024.
  • Over the past 4 years, Treace Medical Concepts' Non Operating Investment Income (Quarter) stood at -$27000.0 in 2022, then skyrocketed by 1251.85% to $311000.0 in 2023, then tumbled by 130.23% to -$94000.0 in 2024, then surged by 135.11% to $33000.0 in 2025.
  • Its last three reported values are $33000.0 in Q3 2025, -$7000.0 for Q2 2025, and -$40000.0 during Q1 2025.